AstraZeneca says FDA approves drug for rare kidney disease in adults - Reuters

More in Health

• Opinion: The inherited disease my family called ‘it’ had a name, which changed everything

  The journey from the family's first encounter with symptoms to the recognition of the inherited condition "it" took decades, with each generation contributing to the knowledge base. The process involved hundreds of researchers dedicating their careers to understanding the rare disease, leading to the creation of a name that finally provided clarity. The recognition of the disease's existence meant that families could start to manage the symptoms and seek the appropriate care, rather than just coping with the unkno…

  6 min read
• STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction

  ### Briefing: Off-Label GLP-1 Prescriptions for Addiction Surge in Telehealth For popular diabetes and obesity medications known as GLP-1s, addiction medicine is one of the promising next acts. Baseline Therapeutics is studying a GLP-1 receptor agonist in alcohol, cocaine, and methamphetamine use disorders; Altimmune is testing one called pemvidutide for alcohol use disorder. Addiction medicine specialists are hopeful that the Food and Drug Administration may soon approve a new medication for alcohol use disorder…

  1 min read
• Facial laser session leaves woman with burns; consumer panel orders Rs 1.11 lakh payout

  A Bengaluru district consumer commission has ordered a beauty clinic to pay Rs 1.11 lakh in damages and litigation costs to a woman who suffered facial burns following a laser hair removal procedure. The commission, which held the clinic liable for deficiency in service and unfair trade practice, directed the clinic to refund Rs 1,100 with interest, pay Rs 1 lakh in damages for skin damage and mental agony, and Rs 10,000 towards litigation costs. The clinic was also directed to comply with the order within 45 days…

  3 min read